Thomas Catinazzo, Chief Financial Officer at Relay Therapeutics, Inc. (RLAY), sold 17,717 shares at $12.86 ($228K) on 2026-05-14, disclosed to the SEC on 2026-05-14.
Scheduled sale ($228k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RLAY | SELL | 2026-07-30 | $27K | — | Filing → |
| RLAY | SELL | 2026-07-08 | $331K | — | Filing → |
| RLAY | SELL | 2026-06-24 | $3.2M | — | Filing → |